Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Nov 6, 2014; 3(4): 210-219
Published online Nov 6, 2014. doi: 10.5527/wjn.v3.i4.210
Published online Nov 6, 2014. doi: 10.5527/wjn.v3.i4.210
Metabolic syndrome and chronic kidney disease: Current status and future directions
G V Ramesh Prasad, Department of Medicine, University of Toronto, Ontario M5C 2T2, Canada
Author contributions: Prasad GVR contributed to this paper.
Correspondence to: G V Ramesh Prasad, MBBS, MSc, FRCP(C), FACP, FASN, Associate Professor of Medicine, University of Toronto, 61 Queen Street East, 9th Floor, Toronto, Ontario M5C 2T2, Canada. prasadr@smh.ca
Telephone: +1-416-8673722 Fax: +1-416-8673709
Received: June 25, 2014
Revised: August 26, 2014
Accepted: September 23, 2014
Published online: November 6, 2014
Processing time: 135 Days and 14.8 Hours
Revised: August 26, 2014
Accepted: September 23, 2014
Published online: November 6, 2014
Processing time: 135 Days and 14.8 Hours
Core Tip
Core tip: Metabolic syndrome is associated with chronic kidney disease but its role in chronic kidney disease incidence and progression has not been established. When both these conditions are present, management should be targeted to individual risk factors for kidney disease progression and cardiovascular disease.